GlycoMimetics Inc (GLYC)
0.2642
-0.03
(-11.34%)
USD |
NASDAQ |
May 10, 16:00
0.2652
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Market Cap: 17.03M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 19.21M |
| May 08, 2024 | 19.23M |
| May 07, 2024 | 19.68M |
| May 06, 2024 | 20.33M |
| May 03, 2024 | 117.94M |
| May 02, 2024 | 110.85M |
| May 01, 2024 | 104.41M |
| April 30, 2024 | 116.01M |
| April 29, 2024 | 99.90M |
| April 26, 2024 | 105.70M |
| April 25, 2024 | 110.21M |
| April 24, 2024 | 119.56M |
| April 23, 2024 | 118.27M |
| April 22, 2024 | 116.01M |
| April 19, 2024 | 124.07M |
| April 18, 2024 | 139.21M |
| April 17, 2024 | 146.95M |
| April 16, 2024 | 138.57M |
| April 15, 2024 | 145.34M |
| April 12, 2024 | 154.68M |
| April 11, 2024 | 161.45M |
| April 10, 2024 | 157.90M |
| April 09, 2024 | 172.73M |
| April 08, 2024 | 166.93M |
| April 05, 2024 | 177.24M |
| Date | Value |
|---|---|
| April 04, 2024 | 174.66M |
| April 03, 2024 | 178.21M |
| April 02, 2024 | 190.77M |
| April 01, 2024 | 195.93M |
| March 28, 2024 | 193.35M |
| March 27, 2024 | 204.95M |
| March 26, 2024 | 183.68M |
| March 25, 2024 | 181.75M |
| March 22, 2024 | 188.84M |
| March 21, 2024 | 185.62M |
| March 20, 2024 | 196.57M |
| March 19, 2024 | 188.84M |
| March 18, 2024 | 180.46M |
| March 15, 2024 | 164.99M |
| March 14, 2024 | 168.07M |
| March 13, 2024 | 164.20M |
| March 12, 2024 | 168.71M |
| March 11, 2024 | 164.85M |
| March 08, 2024 | 175.79M |
| March 07, 2024 | 180.30M |
| March 06, 2024 | 186.74M |
| March 05, 2024 | 186.74M |
| March 04, 2024 | 195.76M |
| March 01, 2024 | 193.82M |
| February 29, 2024 | 186.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
17.03M
Minimum
May 10 2024
555.74M
Maximum
May 16 2019
141.69M
Average
120.94M
Median
Aug 05 2019
Market Cap Benchmarks
| Altimmune Inc | 512.22M |
| Lyell Immunopharma Inc | 629.70M |
| Amicus Therapeutics Inc | 2.728B |
| InfuSystems Holdings Inc | 155.23M |
| Nanoviricides Inc | 21.79M |
Market Cap Related Metrics
| Price to Book Value | 0.4433 |
| Price | 0.2642 |
| Earnings Yield | -219.5% |